World Health Organization characterizes pharmacovigilance as the science and exercises identifying with the discovery, evaluation, comprehension and avoidance of unfavorable impacts or some other drugrelated problemâ€Â. When a medication is discharged in the market by FDA, it is checked for its wellbeing profile. Further, the antagonistic impacts brought about by the medication are accounted for to produce post-showcasing reconnaissance information. Lipika Chablani, Pharmacovigilance of Biosimilars. Diary of Pharmacovigilance is an Open Access diary and expects to distribute generally complete and solid wellspring of data on the revelations and current improvements in the method of unique articles, survey articles, case reports, short correspondences, and so forth in every aspect of the field and making them uninhibitedly accessible through online with no limitations or some other memberships to scientists around the world. The Journal of Pharmacovigilance is an open access peer-checked on diary. Our full open-get to strategy, which makes all distributed material quickly accessible to people in general and it is particularly pertinent with regards to data about medications wellbeing and harmfulness.
